Guideline-directed antihypertensive medication use among young adult participants with uncontrolled hypertension at enrollment in the MyHEART study.

{"article_title":"Guideline-directed antihypertensive medication use among young adult participants with uncontrolled hypertension at enrollment in the MyHEART study.","author":"Knutson Sinaise, Megan R , Zaborek, Jennifer , Kim, KyungMann , Lauver, Diane R , McBride, Patrick , Pearson, Jane , Licon, Allexa , Joseph, Anupama , Johnson, Heather M , Hoppe, Kara K","journal_title":"BMC cardiovascular disorders","issn":"1471-2261 ; Electronic","isbn":"","publication_date":"20241113","volume":"24","issue":"1","first_page":"636","page_count":"","accession_number":"39538139","doi":"10.1186\/s12872-024-04313-z","publisher":"BioMed Central","doctype":"Journal Article; Multicenter Study; Randomized Controlled Trial","subjects":"Antihypertensive Agents* \/therapeutic use","interest_area":["Cardiology"," Internal\/Family Medicine"],"abstract":"<b>Declarations<\/b><b>Ethics approval and consent to participate<\/b> Participants gave their voluntary, informed consent to participate in the MyHEART Trial. They were reimbursed up to $150 for their participation. This study followed the Declaration of Helsinki principles and Good Clinical Practice Guidelines. This study was approved by the University of Wisconsin Institutional Review Board. <b>Consent for publication<\/b> Not applicable. <b>Competing interests<\/b> The authors declare no competing interests.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=39538139&authtype=shib&custid=ns346513"}